Applications are invited for 9 PhD student positions available in the Marie-Sklodowska-Curie European Training Network: “PRINT-AID – Multidisciplinary European training network for development of personalized anti-infective medical devices combining printing technologies and antimicrobial functionality” within the Horizon 2020 Programme of the European Commission. PRINT-AID aims to provide high-quality research training to Early Stage Researchers. By bringing together experts in antimicrobial drug development, microbial biofilms, 3D-printing technologies, in vivo preclinical infection
Commentary: Worldwide, millions of patients are affected annually by healthcare-associated infection (HCAI), impacting up to 80,000 patients in European Hospitals on any given day. This represents not only public health risk, but also an economic burden. Through its Cooperation in Science and Technology programme (COST), the European Commission has recently funded a four-year initiative to establish a network of stakeholders involved in development, regulation and use of novel anti-microbial coatings for
Over sixty universities, research institutes and companies from twenty-nine European countries will jointly study the impact of applying antimicrobial (nano-)coatings on decreasing the spread of infections. The beneficial aspects of these measures will be assessed in the context of potential environmental adverse effects, as well as development of bacterial resistance. It is the first time that this pressing issue is addressed on such a scale.
Purpose of a Short-Term Scientific Mission STSM facilitates Researchers from COST Countries participating in COST Action [CA 15114] to go to an institution, organisation or research centre in another participating COST Country to foster collaboration and to perform empirical research. Participation of “Early Career Investigators” (ECI) in STSM is particularly encouraged. An applicant can be considered as being an ECI when the time that has
The main objective of AMiCI action is to develop, structure, coordinate and maintain a long-term, flexible and open European network in the field of AMC in healthcare. The scientific field encompasses R&D of materials and coatings, testing, legal aspects and cleaning methods. Research coordination will not only include knowledge institutes, such as universities and applied science institutes, but will also incorporate producers, distributors, processors, policy
Many efforts to reduce AMR have been initiated, are ongoing and have been concluded. However many of these have been proven to be only partially sufficient. In order to succeed, a holistic approach is needed (Communication from the Commission to the European Parliament and the Council – Action plan against the rising threats from Antimicrobial Resistance). AMR is a major European and global societal problem,
Coordination of the best European research resources and capabilities will form the necessary critical mass and develop the most advanced scientific approaches to tackle AMR, reversing its increasing trend, and leading to the sustainable use of antibiotics and treatments for infectious diseases. In this context, the networking efforts of AMICI provide an important link to the EC’s Joint Programming Initiative (JPI) on AMR. This connection
Novel antibiotic drugs are scarce and increasing resistance against antimicrobial drugs is established. Innovations that tackle rising and prominent threats in healthcare are demanded. Preventive innovations are needed to minimize microbial pressure in bacterial “hotspots”, like hospitals, nursing homes or day-care centres. For example, bacteria can persist for many months on inanimate surfaces, forming an ongoing source of transmission. Healthcare workers can transfer these microbes